BJH - volume 4, issue 3, september 2013
F. Van Obbergh MD, A. Van Hoof MD, PhD, G. Verhoef MD, PhD, D. Dierickx MD, PhD, V. De Wilde MD, PhD, F. Offner MD, PhD, D. Bron MD, PhD, A. Sonet MD, M. André MD, PhD, A. Janssens MD, PhD, C. Bonnet MD, B. Deprijck MD, P. Zachée MD, PhD, A. Kentos MD, PhD, W. Schroyens MD, PhD, E. Van den Neste MD, PhD
The sub-committee on lymphoproliferative disorders of the Belgian Hematological Society has met several times to prepare guidelines on the management of patients with peripheral T-cell lymphomas. Each panellist’s expert provided interpretation of the evidence, based on literature review and personal experience. The available evidence was systematically discussed prior to formulating recommendations. A systematic approach to obtain consensus of expert opinion was used. After each meeting, the draft guideline was circulated to all experts for comment and approval. The present guidelines focus on general management of peripheral T-cell lymphomas with special emphasis on more specific disease-adapted strategies.
(BELG J HEMATOL 2013;4(3):90–101)
Read moreBJH - volume 4, issue 2, june 2013
G. Verhoef MD, PhD, W. Schroyens MD, PhD, D. Bron MD, PhD, C. Bonnet MD, V. De Wilde MD, PhD, A. Van Hoof MD, PhD, A. Janssens MD, PhD, D. Dierickx MD, PhD, M. André MD, PhD, E. Van den Neste MD, PhD
The guidelines for adult patients in this article are based on 2011 ESMO and NCCN version 4.2011 guidelines and amended for the particular Belgian context of label prescription and reimbursement. Levels of evidence for the use of treatment recommendations are given in square brackets. Statements without grading were considered justifed standard clinical practice by the experts of the BHS-lymphoma working party.
(BELG J HEMATOL 2013;4(2):51–57)
Read moreBJH - 2013, issue BHS Abstractbook, january 2013
J. Caers MD, PhD, M.C. Vekemans MD, I. Vande Broek MD, PhD, P.H. Mineur , K. Beel MD, PhD, V. Maertens MD, C. Schuermans MD, F. Leleu , G. Vanstraelen , H. Demuynck MD, W. Schroyens MD, PhD, E. Van den Neste MD, PhD, G. Bries MD, PhD, A. Van De Velde MD, PhD, M. Delforge MD, PhD, C. Doyen MD
BJH - 2013, issue BHS Abstractbook, january 2013
W. Schroyens MD, PhD, Z. Berneman MD, PhD, A. Gadisseur MD, PhD, A. Van De Velde MD, PhD, I. Vrelust MD
BJH - 2013, issue BHS Abstractbook, january 2013
I. Bruynseels , S. Ceyssens , A. Van De Velde MD, PhD, W. Schroyens MD, PhD, A. Gadisseur MD, PhD, Z. Berneman MD, PhD, I. Vrelust MD
BJH - 2013, issue BHS Abstractbook, january 2013
B. Hodossy MD, S. Helsen , A. Verlinden MD, PhD, A. Van De Velde MD, PhD, A. Gadisseur MD, PhD, W. Schroyens MD, PhD, Z. Berneman MD, PhD, I. Vrelust MD
BJH - 2013, issue BHS Abstractbook, january 2013
A. Van De Velde MD, PhD, E. Vermander , I. Vrelust MD, I. Vandenbosch , A. Gadisseur MD, PhD, W. Schroyens MD, PhD, Z.N. Berneman MD, PhD
Top
